INNOPRAN XL Trademark

Trademark Overview

On Friday, October 23, 2015, a trademark application was filed for INNOPRAN XL with the United States Patent and Trademark Office. The USPTO has given the INNOPRAN XL trademark a serial number of 86797512. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Wednesday, November 3, 2021. This trademark is owned by Akrimax Pharmaceuticals, LLC. The INNOPRAN XL trademark is filed in the Pharmaceutical Products category with the following description:

Cardiovascular pharmaceuticals
innopran xl

General Information

Serial Number86797512
Word MarkINNOPRAN XL
Filing DateFriday, October 23, 2015
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateWednesday, November 3, 2021
Registration Number4988076
Registration DateTuesday, June 28, 2016
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 12, 2016

Trademark Statements

Goods and ServicesCardiovascular pharmaceuticals
NOT AVAILABLE"XL"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, October 28, 2015
Primary Code005
First Use Anywhere DateSunday, March 30, 2003
First Use In Commerce DateSunday, March 30, 2003

Trademark Owner History

Party NameANI PHARMACEUTICALS, INC.
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressBAUDETTE, MN 56623
Party NameAkrimax Pharmaceuticals, LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressCranford, NJ 07016
Party NameAkrimax Pharmaceuticals, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressCranford, NJ 07016
Party NameAkrimax Pharmaceuticals, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressCranford, NJ 07016

Trademark Events

Event DateEvent Description
Wednesday, October 28, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, February 9, 2016ASSIGNED TO EXAMINER
Tuesday, February 9, 2016EXAMINERS AMENDMENT E-MAILED
Tuesday, February 9, 2016EXAMINERS AMENDMENT -WRITTEN
Tuesday, February 9, 2016NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, February 9, 2016EXAMINER'S AMENDMENT ENTERED
Monday, March 7, 2016ASSIGNED TO LIE
Tuesday, April 12, 2016PUBLISHED FOR OPPOSITION
Tuesday, April 12, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 28, 2016REGISTERED-PRINCIPAL REGISTER
Wednesday, April 5, 2017AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Friday, November 17, 2017TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, October 27, 2015NEW APPLICATION ENTERED
Tuesday, February 9, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, March 10, 2016LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, March 23, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, November 17, 2017ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, June 28, 2021COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Wednesday, November 3, 2021CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, November 3, 2021REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Wednesday, November 3, 2021NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Monday, June 6, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, June 6, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, June 6, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, July 28, 2021TEAS SECTION 8 & 15 RECEIVED
Friday, March 31, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, March 31, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, March 31, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, March 31, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, February 28, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, February 28, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, February 28, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, March 31, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Saturday, June 28, 2025COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

Related Keywords

innopran pharmaceuticals cardiovascular